PDLIM5 improves depression-like behavior of prenatal stress offspring rats via methylation in male, but not female. 2020

Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
Central Laboratory, Heze Medical College, Heze, 274000, China.

Prenatal stress (PS) contributes to depression-like behavior in the offspring. PDLIM5 is involved in the onset of mental disorders. This study is to investigate the role and mechanism of PDLIM5 in depression-like behavior of PS offspring rats. PS model was used to analyze the effects of different treatments to PS offspring rats with different sex, including PDLIM5, PDLIM5 shRNA and 5-aza-2' -deoxycytidine (5-azaD). The depression-like behavior was assessed by the sucrose preference test (SPT) and forced swimming test (FST). The mRNA and protein expression levels of PDLIM5 in the hippocampus of PS offspring rats were detected by qRT-PCR and western blot, respectively. The methylation of PDLIM5 promoter were analyzed by bisulfite sequencing. Our data revealed that PS offspring rats showed a significant decrease in sucrose preference and a prolonged immobility time. Injection of PDLIM5 significantly improved the depression-like behavior in PS offspring rats, whereas administration of PDLIM5 shRNA aggravated it. In addition, PDLIM5 expression was decreased at the mRNA and protein levels, and the methylation level of PDLIM5 promoter was increased in hippocampus of PS male but not female offspring rats. Furthermore, microinjection of 5-azaD improved the PS induced depression-like behavior in offspring rats. Moreover, in male PS offspring rats, microinjection of 5-azaD reversed the effect of PS on PDLIM5 expression and promoter methylation. PDLIM5 can significantly improve the depression-like behavior of both male and female PS offspring rats, while the PDLIM5 promoter methylation is only observed in male PS offspring rats. Our study may provide new mechanism for the pathogenesis of depression and experimental evidence for sex-based precise treatment.

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums

Related Publications

Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
June 2018, Neuroscience,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
January 2024, Life sciences,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
February 2019, Behavioural brain research,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
December 2017, Neurochemical research,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
May 2021, Naunyn-Schmiedeberg's archives of pharmacology,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
February 2024, Biology of sex differences,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
April 2024, Biology of sex differences,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
January 2002, Molecular psychiatry,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
December 1999, Pharmacology, biochemistry, and behavior,
Yong Lu, and Jiguo Jiang, and Jingfang Si, and Qi Wu, and Fengjuan Tian, and Keling Jiao, and Yingjun Mu, and Peng Dong, and Zhongliang Zhu
January 1995, Neurotoxicology and teratology,
Copied contents to your clipboard!